Curium ECLIPSE

This is a prospective, randomized, open-label, multicenter Phase 3 study evaluating the efficacy and safety of 177Lu-PSMA-I&T versus a switch in standard of care hormone therapy in men with metastatic

Trial overview

Topic

Curium ECLIPSE

Description

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Physicians

Contact

Florida East Coast - Aventura

Peggy Mouradian & Nancy Joseph 

Florida East Coast - Jacksonville

Maddie Hamilton

Florida East Coast - Boca Raton and Plantation

Peggy Mouradian

Forida West Coast - Fort Myers

Lauren Embry